Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem.
Lalueza A, Lora-Tamayo J, Maestro-de la Calle G, Folgueira D, Arrieta E, de Miguel-Campo B, Díaz-Simón R, Lora D, de la Calle C, Mancheño-Losa M, Marchán-López Á, García-Reyne A, Fernández-Ruiz M, Sayas-Catalán J, Serrano A, Cueto-Felgueroso C, San Juan R, García-García R, Catalán M, Villena V, Aguado JM, Lumbreras C; COVID+12 group. Lalueza A, et al. Among authors: de la calle c, de miguel campo b. Intern Emerg Med. 2022 Mar;17(2):515-524. doi: 10.1007/s11739-021-02748-2. Epub 2021 Apr 29. Intern Emerg Med. 2022. PMID: 33914228 Free PMC article.
The early use of sepsis scores to predict respiratory failure and mortality in non-ICU patients with COVID-19.
Lalueza A, Lora-Tamayo J, de la Calle C, Sayas-Catalán J, Arrieta E, Maestro G, Mancheño-Losa M, Marchán-López Á, Díaz-Simón R, García-García R, Catalán M, García-Reyne A, de Miguel-Campo B, Lumbreras C; COVID+12 Group. Lalueza A, et al. Among authors: de la calle c, de miguel campo b. Rev Clin Esp (Barc). 2022 May;222(5):293-298. doi: 10.1016/j.rceng.2020.10.004. Epub 2021 Feb 17. Rev Clin Esp (Barc). 2022. PMID: 35512908 Free PMC article.
Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection.
de la Calle C, Lalueza A, Mancheño-Losa M, Maestro-de la Calle G, Lora-Tamayo J, Arrieta E, García-Reyne A, Losada I, de Miguel B, Díaz-Simón R, López-Medrano F, Fernández-Ruiz M, Carretero O, San Juan R, Aguado JM, Lumbreras C. de la Calle C, et al. Among authors: de miguel b. Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1209-1216. doi: 10.1007/s10096-020-04150-w. Epub 2021 Jan 7. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33409832 Free PMC article.
[The early use of sepsis scores to predict respiratory failure and mortality in non-ICU patients with COVID-19].
Lalueza A, Lora-Tamayo J, de la Calle C, Sayas-Catalán J, Arrieta E, Maestro G, Mancheño-Losa M, Marchán-López Á, Díaz-Simón R, García-García R, Catalán M, García-Reyne A, de Miguel-Campo B, Lumbreras C; Grupo COVID 12. Lalueza A, et al. Among authors: de la calle c, de miguel campo b. Rev Clin Esp. 2022 May;222(5):293-298. doi: 10.1016/j.rce.2020.10.004. Epub 2020 Nov 7. Rev Clin Esp. 2022. PMID: 33191944 Free PMC article. Spanish.
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.
Fernández-Ruiz M, López-Medrano F, Pérez-Jacoiste Asín MA, Maestro de la Calle G, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Pablos JL, Ripoll M, San Juan R, Trujillo H, Lumbreras C, Aguado JM. Fernández-Ruiz M, et al. Among authors: de la calle c. J Med Virol. 2021 Feb;93(2):831-842. doi: 10.1002/jmv.26308. Epub 2020 Jul 27. J Med Virol. 2021. PMID: 32672860 Free PMC article.
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study.
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Maestro-de la Calle G, Sánchez-Fernández M, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, San Juan R, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM. de la Calle C, et al. Among authors: de miguel b. Int J Infect Dis. 2021 Apr;105:319-325. doi: 10.1016/j.ijid.2021.02.041. Epub 2021 Feb 13. Int J Infect Dis. 2021. PMID: 33592340 Free PMC article.
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study.
López-Medrano F, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Carretero O, Lalueza A, Maestro de la Calle G, Caro JM, de la Calle C, Catalán M, García-García R, Martínez-López J, Origüen J, Ripoll M, San Juan R, Trujillo H, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Gómez C, Silva JT, García-Ruiz de Morales D, Saro-Buendía M, Marrero-Sánchez Á, Chiara-Graciani G, Bueno H, Paz-Artal E, Lumbreras C, Pablos JL, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. López-Medrano F, et al. Among authors: de la calle c, de miguel b. Int J Infect Dis. 2021 Apr;105:487-494. doi: 10.1016/j.ijid.2021.02.099. Epub 2021 Feb 26. Int J Infect Dis. 2021. PMID: 33647515 Free PMC article.
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
San-Juan R, Fernández-Ruiz M, López-Medrano F, Carretero O, Lalueza A, Maestro de la Calle G, Pérez-Jacoiste Asín MA, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Parra P, Ripoll M, Ruiz-Merlo T, Trujillo H, Pablos JL, Paz-Artal E, Lumbreras C, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group, the Spanish Network for Research in Infectious Diseases (REIPI). San-Juan R, et al. Among authors: de la calle c, de miguel b. Int J Infect Dis. 2022 Apr;117:56-64. doi: 10.1016/j.ijid.2022.01.040. Epub 2022 Jan 23. Int J Infect Dis. 2022. PMID: 35081417 Free PMC article.
Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019.
Serrano M, Espinosa G, Lalueza A, Bravo-Gallego LY, Diaz-Simón R, Garcinuño S, Gil-Etayo J, Moises J, Naranjo L, Prieto-González S, Ruiz-Ortiz E, Sánchez B, Moreno-Castaño AB, Díaz-Pedroche C, Viñas-Gomis O, Cervera R, Serrano A; APS-COVID 19 Study Group/European Forum on Antiphospholipid Antibodies. Serrano M, et al. ACR Open Rheumatol. 2021 Apr;3(4):267-276. doi: 10.1002/acr2.11245. Epub 2021 Mar 19. ACR Open Rheumatol. 2021. PMID: 33738987 Free PMC article.
Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis.
De la Calle C, Ternavasio-de la Vega HG, Morata L, Marco F, Cardozo C, García-Vidal C, Del Rio A, Cilloniz C, Torres A, Martínez JA, Mensa J, Soriano A. De la Calle C, et al. J Infect. 2018 Apr;76(4):342-347. doi: 10.1016/j.jinf.2018.01.003. Epub 2018 Jan 31. J Infect. 2018. PMID: 29360520 Free article.
77 results